-
1 Comment
Da An Gene Co., Ltd. of Sun Yat-Sen University is currently in a long term downtrend where the price is trading 5.1% below its 200 day moving average.
From a valuation standpoint, the stock is 50.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Da An Gene Co., Ltd. of Sun Yat-Sen University's total revenue rose by 439.2% to $2B since the same quarter in the previous year.
Its net income has increased by 7492.4% to $912M since the same quarter in the previous year.
Finally, its free cash flow grew by 510.3% to $1B since the same quarter in the previous year.
Based on the above factors, Da An Gene Co., Ltd. of Sun Yat-Sen University gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000001KP1 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | 0.64 |
|---|---|
| PE Ratio | None |
| Target Price | 14.58 |
| Dividend Yield | 0.3% |
| Market Cap | 8B |
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through Biological Products and Related Business and Financial Business segments. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, public health, tumor maker, and nucleic acid extraction, as well as polymerase chain reaction, sample preparation, and nucleic extraction systems for molecular diagnosis; COVID-19 rapid test kit and chemiluminescence immunoassay analyzers for immunoassay; liquid based cytology production and automatic sample transfer machines for pathology tests; and auto biochemistry analyzers and chemistry reagents for clinical chemistry. It also provides medical laboratory and health consultation services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company sells its products under the Daan Gene, Darui Biology, LBP, and Zhongshan Bio-Tech brands. In addition, it is involved in biological technology, biomedicine and biopharmaceutical, clinical test, business, software development, trading, hospital investment management, capital market, insurance agent, management, finance lease, microfinance, commercial factoring, loan, consulting, and technology promotion and application service industry services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. Daan Gene Co., Ltd. was founded in 1988 and is headquartered in Guangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002030.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
